Koji Iihara
- Neurology top 0.2%
- Intracranial Aneurysms: Treatment and Complications 117
- Vascular Malformations Diagnosis and Treatment 47
- Traumatic Brain Injury and Neurovascular Disturbances 31
-
- Cerebrovascular and Carotid Artery Diseases 110
- Neurology top 2%
- Intracranial Aneurysms: Treatment and Complications 117
- Vascular Malformations Diagnosis and Treatment 47
- Traumatic Brain Injury and Neurovascular Disturbances 31
- Rheumatology top 1%
- Moyamoya disease diagnosis and treatment 40
- Genetics top 2%
- Glioma Diagnosis and Treatment 31
-
- Acute Ischemic Stroke Management 76
-
- Cardiovascular Health and Disease Prevention 25
Koji Iihara
303 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Neurology 2.5k
- Pulmonary and Respiratory Medicine 1.9k
- Neurology 418
- Rheumatology 754
- Genetics 522
Countries citing papers authored by Koji Iihara
This map shows the geographic impact of Koji Iihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Iihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Iihara more than expected).
Fields of papers citing papers by Koji Iihara
This network shows the impact of papers produced by Koji Iihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Iihara. The network helps show where Koji Iihara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Koji Iihara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 26 | |
| 13 | 2018 | 7 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 4 | |
| 16 | 2018 | 2 | |
| 17 | 2017 | 12 | |
| 18 | 2016 | 31 | |
| 19 | 2012 | 14 | |
| 20 | 2010 | 19 |
About Koji Iihara
Koji Iihara is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Genetics, having authored 328 papers that have together received 6.3k indexed citations. Recurring topics across this work include Intracranial Aneurysms: Treatment and Complications (117 papers), Cerebrovascular and Carotid Artery Diseases (110 papers), Acute Ischemic Stroke Management (76 papers), Vascular Malformations Diagnosis and Treatment (47 papers), Moyamoya disease diagnosis and treatment (40 papers), Glioma Diagnosis and Treatment (31 papers), Traumatic Brain Injury and Neurovascular Disturbances (31 papers) and Cardiovascular Health and Disease Prevention (25 papers). The work is most often cited by research in Neurology (2.5k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Neurology (418 citations). Koji Iihara has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Izumi Nagata, Nobuyuki Sakai, Susumu Miyamoto, Jun Takahashi, Hiroharu Kataoka, Kenichi Murao, Michael Tymianski, Tetsu Satow, Michelle Aarts and John F. MacDonald. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.